Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02994277Not ApplicableCompleted

Artificial Pancreas in Latin America

Role: collaborator

NCT05329714Recruiting

PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

Role: collaborator

NCT05735782Unknown

Clinical and Biological Characterization of Post COVID-19 Syndrome

Role: collaborator

NCT04793165Not ApplicableCompleted

Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting

Role: collaborator

NCT01900912Not ApplicableCompleted

Evaluating the Impact of Community Led Total Sanitation Programs in Mali

Role: lead

NCT00699387Not ApplicableCompleted

Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

Role: collaborator

NCT00799916Phase 3Completed

Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis

Role: lead

All 7 trials loaded